Shares of CRH Medical Corp (NYSEAMERICAN:CRHM) have received an average rating of “Buy” from the ten analysts that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $7.50.
Several analysts have commented on the company. Zacks Investment Research downgraded CRH Medical from a “hold” rating to a “sell” rating in a research note on Tuesday, November 14th. Morgan Stanley upgraded CRH Medical from an “equal weight” rating to an “overweight” rating in a research note on Friday, November 17th.
Shares of CRH Medical (NYSEAMERICAN CRHM) opened at $2.75 on Friday. The firm has a market capitalization of $196.44, a P/E ratio of 39.29 and a beta of 1.32. CRH Medical has a 52 week low of $1.46 and a 52 week high of $9.25.
TRADEMARK VIOLATION NOTICE: This story was originally posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this story on another publication, it was copied illegally and republished in violation of U.S. and international copyright laws. The legal version of this story can be viewed at https://www.chaffeybreeze.com/2018/01/05/crh-medical-corp-crhm-receives-consensus-rating-of-buy-from-brokerages.html.
About CRH Medical
CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.